Procurement-ready nuclease for reducing DNA and RNA burden in protein extraction and purification streams, supporting lysate handling, filtration performance, downstream compatibility, and lot-to-lot control.
Request pricingProtein production does not stop at expression. Once cells are disrupted, DNA and RNA can turn a manageable lysate into a viscous, difficult-to-process stream that slows clarification, loads filters, and complicates downstream separation. Strandfall Nuclease is supplied for controlled nucleic acid reduction in protein-containing process streams, helping teams move from crude lysate to cleaner, more predictable purification input.
Built for B2B process use, this nuclease supports residual nucleic acid reduction without forcing unnecessary complexity into your workflow. It is suited for development, scale-up, and routine production environments where handling, compatibility, and documentation matter.
Nuclease degrades DNA and RNA into smaller fragments, reducing nucleic acid-driven viscosity and improving the physical behavior of lysates or intermediate process streams. In protein extraction and purification, that can translate into:
The goal is not simply nucleic acid digestion. The goal is a process stream that behaves more predictably.
Following lysis, nucleic acids released from host cells can increase viscosity and make solids separation less efficient. Adding nuclease at this stage can help convert a difficult lysate into a more workable suspension before primary clarification.
Nucleic acid-rich material can contribute to early filter loading and variable throughput. Nuclease treatment helps reduce this burden so filtration steps are less dependent on the nucleic acid profile of each batch.
Residual DNA and RNA may interfere with downstream protein purification behavior, depending on the protein, host system, and separation strategy. Nuclease treatment upstream can improve consistency in the material presented to later purification steps.
Nuclease is often evaluated when teams are comparing lysis strategies, clarification formats, feed preparation methods, or impurity reduction plans. Strandfall supports this work with a procurement-friendly supply format and application-focused technical discussion.
High-viscosity lysates slow transfers, complicate sampling, and make clarification harder to control. Nuclease helps break down the nucleic acid structures that drive viscosity, improving the mechanical handling of the stream.
By reducing long nucleic acid chains, nuclease treatment can support clearer pre-purification material and cleaner separation boundaries during clarification.
Protein purification workflows depend on predictable inputs. Strandfall Nuclease is selected for use in process streams where the enzyme must support nucleic acid reduction while fitting into existing buffer, timing, and separation decisions.
Industrial protein workflows need repeatable raw material behavior. Strandfall provides controlled lot documentation, traceability, and release information appropriate for purchasing, quality review, and process records.
Strandfall Nuclease may be used in workflows involving:
Suitability should be confirmed in the actual process matrix, especially where the target protein is sensitive to buffer composition, hold time, or shear conditions.
Nuclease performance depends on the process environment. When evaluating Strandfall Nuclease, teams typically review:
Strandfall can help align nuclease selection with your operating window without disclosing proprietary activity-unit methods or trader-confidential assay details.
For industrial buyers, enzyme performance must be paired with supply control. Strandfall supports procurement teams with practical documentation and clear ordering conversations.
Available support may include:
If your team is qualifying nuclease for routine production, early discussion of packaging, forecast volume, and documentation expectations helps reduce purchasing friction later.
A practical evaluation should compare treated and untreated process streams under your normal operating constraints. Useful observations include:
This keeps the evaluation focused on operational outcomes rather than isolated bench observations.
Tell us your host system, process stage, expected order scale, and documentation requirements. Strandfall will respond with pricing and supply options for nuclease used in protein extraction and purification workflows.
Prefer a short specification review first? Use the same form and note that you would like to get pricing after technical fit is confirmed.



Tell us your application and volume — we reply with pricing and lead time.